Year : 2018 | Volume
: 14 | Issue : 7 | Page : 1578--1582
Diagnosis and treatment of hemangiopericytoma in the central nervous system
Fang Liu1, Boning Cai1, Yu Du2, Yurong Huang1
1 Department of Radiation Oncology, Chinese PLA General Hospital, Beijing, China
2 Department of Radiation Oncology, First Affiliated Hospital of PLA General Hospital, Beijing, China
Objective: This study aimed to explore the clinical characteristics and treatment of the hemangiopericytoma (HPC) in the central nervous system.
Materials and Methods: Clinical data from 14 patients with HPC in the central nervous system who were followed up for 12–107 months were retrospectively analyzed, and relevant literature was reviewed.
Results: All 14 patients underwent surgery and postoperative pathologic diagnosis, including 8 cases of total excision, 3 cases of subtotal excision, and 3 cases of partial excision. There were 7 recurrent cases (50%, 4 cases of total excision, 1 case of subtotal excision, and 2 cases of partial excision, none of them received postoperative radiotherapy) with a median relapse time of 39 months, where the median relapse time after total excision was 41.5 months, and after nontotal excision was 17 months. In addition, patients could survive for a long time after reoperation following relapse and after receiving postoperative radiotherapy.
Conclusion: The diagnosis of HPC depends on the pathology. Currently, the surgery and postoperative radiotherapy provide a good treatment results, while the wholeness of surgical resection is of particular importance.
Department of Radiation Oncology, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing-100853
|How to cite this article:|
Liu F, Cai B, Du Y, Huang Y. Diagnosis and treatment of hemangiopericytoma in the central nervous system.J Can Res Ther 2018;14:1578-1582
|How to cite this URL:|
Liu F, Cai B, Du Y, Huang Y. Diagnosis and treatment of hemangiopericytoma in the central nervous system. J Can Res Ther [serial online] 2018 [cited 2022 Oct 3 ];14:1578-1582
Available from: https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2018;volume=14;issue=7;spage=1578;epage=1582;aulast=Liu;type=0